Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Zbigniew Deroń

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

scientific article published on 07 February 2020

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

scientific article published on 13 December 2019

Comparison of (99m)Tc-HEPIDA and (99m)Tc-MBrIDA from the standpoint of hepatic clearance determination-- preliminary communication

scientific article published on 01 January 2009

Diagnostic value of optimised real-time sonoelastography in the assessment of liver fibrosis in chronic hepatitis B and C.

scientific article

Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population

scientific article published on 28 November 2016

Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study

scientific article published on 28 November 2016

Epidemiology of hepatitis C virus infections in Łódzkie voivodeship

scientific article published on January 2016

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

scientific article published on 01 May 2021

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

scientific article published on 13 January 2022

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

scientific article published in September 2022

Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?

scientific article published in February 2018

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all HCV infected patients in the real-world experience?

scientific article published on 10 November 2020

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

scientific article published on 13 June 2020

Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)

scientific article published on 01 January 2011

Prevalence of HCV genotypes in Poland - the EpiTer study

scientific article published on 28 November 2016

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.

scientific article

Ribavirin priming has no beneficial effects for chronic hepatitis C patients.

scientific article published on January 2014

Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients - short report

scientific article published on 17 February 2020

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases

[Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report]

scientific article published on 01 January 2007

[Complete atrio-ventricular block as a first symptom of borreliosis: antibiotic treatment instead of pacemaker implantation]

scientific article published on 01 January 2013

Paulina is supported by:

About Paulina

Help